G D Gutknecht - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

G D Gutknecht

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Obstetrics and Gynecology|May 1, 1976

Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositoriesE M Southern, G D Gutknecht

The Journal of Reproductive Medicine|September 1, 1975

The termination of human pregnancy with prostaglandin analogsG D Gutknecht, E M Southern

British Journal of Obstetrics and Gynaecology|June 1, 1978

Vaginal prostaglandin E2 in the management of fetal intrauterine deathE M Southern, G D Gutknecht, N R Mohberg, et al.

Journal of Biological Response Modifiers|August 1, 1986

Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patientsA Rios, D A Stringfellow, F A Fitzpatrick, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Obstetrics and Gynecology|May 1, 1976

Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositoriesE M Southern, G D Gutknecht

The Journal of Reproductive Medicine|September 1, 1975

The termination of human pregnancy with prostaglandin analogsG D Gutknecht, E M Southern

British Journal of Obstetrics and Gynaecology|June 1, 1978

Vaginal prostaglandin E2 in the management of fetal intrauterine deathE M Southern, G D Gutknecht, N R Mohberg, et al.

Journal of Biological Response Modifiers|August 1, 1986

Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patientsA Rios, D A Stringfellow, F A Fitzpatrick, et al.

Pageof 1